Tags : QR-421

Clinical Trials

ProQR Reports Results of QR-421 in P-I/II Stellar Trial for

Shots: The P-I/II Stellar trial involve assessing QR-421a in 20 patients with usher syndrome and non-syndromic retinitis pigmentosa (nsRP) due to USH2A exon 13 mutations for 24mos. Results: QR-421 demonstrated benefit on multiple measures of vision, including best-corrected visual activity (BCVA), static perimetry, and retinal imaging (OCT) and was well-tolerated with no observed SAEs and […]Read More